Counting the lifetime cost of obesity: Analysis based on national England data.
HRCU
ICB
QALY
costs
index of multiple deprivation
life years
life years lost
mortality
obesity
Journal
Diabetes, obesity & metabolism
ISSN: 1463-1326
Titre abrégé: Diabetes Obes Metab
Pays: England
ID NLM: 100883645
Informations de publication
Date de publication:
05 Feb 2024
05 Feb 2024
Historique:
revised:
13
12
2023
received:
14
11
2023
accepted:
23
12
2023
medline:
5
2
2024
pubmed:
5
2
2024
entrez:
5
2
2024
Statut:
aheadofprint
Résumé
Obesity has a significant impact on all-cause mortality rate and overall health care resource use (HCRU). These outcomes are also strongly linked to age, sex and local deprivation of the population. We aimed to establish the lifetime costs of obesity by demographic group/geographic area using published mortality rates and HCRU use for integrated care boards (ICB) in England in the context of costs of therapeutic intervention. Population and expected mortality rates by age, sex and deprivation were obtained from national data. Obesity class prevalence was taken from the health of the nation study. The published impact of obesity by age, group, sex and deprivation on mortality and HCRU were applied to estimate life years lost and lifetime HCRU [by sex, age band and body mass index (BMI) class for each ICB]. The year 2019 was chosen as the study basis data to avoid influences of COVID-19 pandemic on obesity rates with application of 2022/23 HCRU values. Outcomes including prevalence, deaths, life years lost, HCRU and lifetime HCRU were compared by age and sex groups across four BMI classes normal/underweight (BMI <25 kg/m Total population aged >16 years was 45.4 million (51% female). 13.7 million (28% of the total adult population) had a BMI ≥30 mg/m The expected increases in annual HCRU because of obesity, when considered over a lifetime, are being mitigated by the increased mortality of obese individuals. Our data suggest that simple short-term HCRU reduction brought about through BMI reduction will be insufficient to fund additional specialist weight reduction interventions. The HRCUs associated with BMI are not in most cases related to short-term health conditions. They are a cumulative result over a number of years, so for age 16-49 years reducing BMI from ≥40 to 30-39.9 kg/m
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Diabetes, Obesity and Metabolism published by John Wiley & Sons Ltd.
Références
Blüher M. Obesity: global epidemiology and pathogenesis. Nat Rev Endocrinol. 2019;15(5):288-298. doi:10.1038/s41574-019-0176-8 PMID: 30814686. 288-298.
Kivimäki M, Strandberg T, Pentti J, et al. Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study. Lancet Diabetes Endocrinol. 2022;10(4):253-263. doi:10.1016/S2213-8587(22)00033-X Epub 2022 Mar 4. PMID: 35248171; PMCID: PMC8938400.
McKinsey Global Institute Overcoming obesity: An initial economic analysis. 2014. https://www.mckinsey.com/~/media/mckinsey/business%20functions/economic%20studies%20temp/our%20insights/how%20the%20world%20could%20better%20fight%20obesity/mgi_overcoming_obesity_full_report.ashx accessed 19 May 2023.
Tremmel M, Gerdtham UG, Nilsson PM, Saha S. Economic burden of obesity: a systematic literature review. Int J Environ Res Public Health. 2017;14(4):435. doi:10.3390/ijerph14040435 PMID: 28422077; PMCID: PMC5409636.
Cawley J, Biener A, Meyerhoefer C, et al. Direct medical costs of obesity in the United States and the most populous states. J Manag Care Spec Pharm. 2021;27(3):354-366. doi:10.18553/jmcp.2021.20410 Epub 2021 Jan 20. PMID: 33470881; PMCID: PMC10394178.
Pearson-Stuttard J, Holloway S, Sommer Matthiessen K, Thompson A, Capucci S. Evolution of healthcare costs for obesity-related complications over 10 years in a UK population: a retrospective open cohort study. Obesity Facts. 2023; PO2.12.
House of Commons Library Obesity Statistics https://researchbriefings.files.parliament.uk/documents/SN03336/SN03336.pdf: accessed 30 September 2023
Tackling obesity The role of the NHS in a whole-system approach Jonathon Holmes July 2021. https://www.kingsfund.org.uk/sites/default/files/2021-07/Tackling%20obesity.pdf accessed 30 September 2023.
Hoogendoorn M, Galekop M, van Baal P. The lifetime health and economic burden of obesity in five European countries: what is the potential impact of prevention? Diabetes Obes Metab. 2023;25(8):2351-2361. doi:10.1111/dom.15116 Epub 2023 May 24. PMID: 37222003.
NHS England Table SAPE22DT6a: Mid-2019 Population Estimates for 2020 by NHS England (Region) by Sustainability Transformation Partnerships (STP) by Clinical Commissioning Group by Single Year of Age and Sex. https://www.ons.gov.uk/peoplepopulationandcommunity/populationandmigration/populationestimates/datasets/clinicalcommissioninggroupmidyearpopulationestimates
NHS England Change to integrated care board (ICB) core services target allocation (waterfalls) analysis v1.0 Index of Multiple Deprivation (IMD) by ICB tab. https://www.england.nhs.uk/publication/change-to-icb-core-services-target-allocation-waterfalls/#:~:text=Commissioning-,Change%20to%20integrated%20care%20board%20(ICB,core%20services%20target%20allocation%20(waterfalls)&text=This%20excel%2Dbased%20tool%20allows,the%20impact%20on%20similar%20ICBs
ONS National life tables: England Period life expectancy by age and sex for England. Each national life table is based on population estimates, births and deaths for a period of three consecutive years. Tables are published annually. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/lifeexpectancies/datasets/nationallifetablesenglandreferencetables/current
ONS Numbers of deaths and age standardised mortality rates by deprivation decile, month and sex: 1 January 2019 to 30 June 2022. https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/deaths/adhocs/15206numbersofdeathsandagestandardisedmortalityratesbydeprivationdecilemonthandsex1january2019to30june2022NHS England allocation of resources 2022/23 https://www.england.nhs.uk/publication/allocation-of-resources-2022-23/
NHS England Allocation of resources 2022/23 https://www.england.nhs.uk/publication/allocation-of-resources-2022-23/
NHS Digital - Acute Patient Level Activity and Costing. Experimental Statistics by Age Group and Sex and Deprivation, Other Reports and Statistics. 2019-20.
Obesity Prevalence by Age, sex and deprivation - NHS Digital Health Survey for England (HSE). https://digital.nhs.uk/data-and-information/publications/statistical/health-survey-for-england/2019
Kent S, Green J, Reeves G, et al. Hospital costs in relation to body-mass index in 1·1 million women in England: a prospective cohort study. Lancet Public Health. 2017:e214. doi:10.1016/S2468-2667(17)30062-2
le Roux CW, Chubb B, Nørtoft E, Borglykke A. Obesity and healthcare resource utilization: results from clinical practice research database (CPRD). Obes Sci Pract. 2018;4(5):409-416. doi:10.1002/osp4.291 PMID: 30338111; PMCID: PMC6180713.
Bhaskaran K, Dos-Santos-Silva I, Leon DA, Douglas IJ, Smeeth L. Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3·6 million adults in the UK. Lancet Diabetes Endocrinol. 2018;6(12):944-953. doi:10.1016/S2213-8587(18)30288-2 Epub 2018 Oct 30. PMID: 30389323; PMCID: PMC6249991.
Ward ZJ, Bleich SN, Long MW, Gortmaker SL. Association of body mass index with health care expenditures in the United States by age and sex. PloS One. 2021;16(3):e0247307. doi:10.1371/journal.pone.0247307 PMID: 33760880; PMCID: PMC7990296.
Fildes A, Charlton J, Rudisill C, Littlejohns P, Prevost AT, Gulliford MC. Probability of an obese person attaining Normal body weight: cohort study using electronic health records. Am J Public Health. 2015;105(9):e54-e59. doi:10.2105/AJPH.2015.302773 Epub 2015 Jul 16. PMID: 26180980; PMCID: PMC4539812.
Gray LA, Breeze PR, Williams EA. BMI trajectories, morbidity, and mortality in England: a two-step approach to estimating consequences of changes in BMI. Obesity (Silver Spring). 2022;30(9):1898-1907. doi:10.1002/oby.23510 Epub 2022 Aug 3. PMID: 35920148; PMCID: PMC9546036.
Pearson-Stuttard J, Banerji T, Capucci S, et al. Real-world costs of obesity-related complications over eight years: a US retrospective cohort study in 28,500 individuals. Int J Obes (Lond). 2023;47:1239-1246. doi:10.1038/s41366-023-01376-4. PMID: 37723273.
Xu H, Li PH, Barrow TM, et al. Obesity as an effect modifier of the association between menstrual abnormalities and hypertension in young adult women: results from project ELEFANT. PloS One. 2018;13(11):e0207929. doi:10.1371/journal.pone.0207929 PMID: 30485368; PMCID: PMC6261602.
Morgan KL, Rahman MA, Macey S, et al. Obesity in pregnancy: a retrospective prevalence-based study on health service utilisation and costs on the NHS. BMJ Open. 2014;4(2):e003983. doi:10.1136/bmjopen-2013-003983 PMID: 24578535; PMCID: PMC3939655.
Tak YJ, Lee SY. Long-term efficacy and safety of anti-obesity treatment: where do we stand? Curr Obes Rep. 2021;10(1):14-30. doi:10.1007/s13679-020-00422-w Epub 2021 Jan 6. PMID: 33410104; PMCID: PMC7787121.
Wilding JPH, Batterham RL, Calanna S, et al. STEP 1 study group. Once-weekly Semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002. doi:10.1056/NEJMoa2032183 Epub 2021 Feb 10. PMID: 33567185.
Semaglutide for managing overweight and obesity Technology appraisal guidance [TA875]Published: 08 March 2023 Last updated: 04 September 2023. https://www.nice.org.uk/guidance/ta875 accessed 28 July 2023.
Aronne LJ, Sattar N, Horn DB, Bays HE, Wharton S, Lin WY, Ahmad NN, Zhang S, Liao R, Bunck MC, Jouravskaya I, Murphy MA. SURMOUNT-4 Investigators. Continued treatment with tirzepatide for maintenance of weight reduction in adults with obesity: the SURMOUNT-4 randomized clinical trial. JAMA. 2024;331(1):38-48.
Jastreboff AM, Kaplan LM, Frías JP, Wu Q, Du Y, Gurbuz S, Coskun T, Haupt A, Milicevic Z, Hartman ML. Retatrutide Phase 2 obesity trial investigators. Triple-hormone-receptor agonist retatrutide for obesity - A phase 2 trial. N Engl J Med. 2023;389(6):514-526.
Harrison S, Dixon P, Jones HE, Davies AR, Howe LD, Davies NM. Long-term cost-effectiveness of interventions for obesity: a mendelian randomisation study. PLoS Med. 2021;18(8):e1003725. doi:10.1371/journal.pmed.1003725 PMID: 34449774; PMCID: PMC8437285.
McNamara S, Schneider PP, Love-Koh J, Doran T, Gutacker N. Quality-adjusted life expectancy norms for the English population. Value Health. 2023;26(2):163-169.
Schell RC, Just DR, Levitsky DA. Methodological challenges in estimating the lifetime medical care cost externality of obesity. J Benefit Cost Anal. 2021;12(3):441-465. doi:10.1017/bca.2021.6 Epub 2021 Jul 27. PMID: 35419252; PMCID: PMC9004795.
Kjellberg J, Tange Larsen A, Ibsen R, Højgaard B. The socioeconomic burden of obesity. Obes Facts. 2017;10(5):493-502. doi:10.1159/000480404 Epub 2017 Oct 12. PMID: 29020681; PMCID: PMC5741162.
Heald A, Montejo AL, Millar H, De Hert M, McCrae J, Correll CU. Management of physical health in patients with schizophrenia: practical recommendations. Eur Psychiatry. 2010;25(Suppl 2):S41-5.
Ashwell M, Gunn P, Gibson S. Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev. 2012;13(3):275-286. doi:10.1111/j.1467-789X.2011.00952.x Epub 2011 Nov 23. PMID: 22106927.